NR565 – Advanced Pharmacology Fundamentals
Exam Study Guide – Final Exam
Exam Format: Non-Cumulative Exam
Question Type: Multiple Choice
Number of Questions: 100
Time Allotted: 120 minutes (1.2 minutes per question)
Testing Timeframe: The final exam will be available starting on
Wednesday Week 8 at 12:01 am MT until Saturday Week 8 at 11:59 pm
MT.
1. Exam Coverage
Content Areas:
Week 5: Pharmacotherapy for Endocrine Disorders
Week 6: Pharmacotherapy for Respiratory Conditions
Week 7: Pharmacotherapy for Gastrointestinal Conditions
Week 8: Complementary and Alternative Therapies
2. Key Concepts to Study
Week 5: Pharmacotherapy for Endocrine Disorders, Chapters 48-49
Radioactive iodine adverse effects
Methimazole indication and MOA
Levothyroxine education, population considerations, monitoring, drug
interactions, dosing, adjustments
Pioglitazone contraindications
Gemfibrozil drug interactions
Insulin detemir dosing, duration, and indications
, Insulin glargine administration
ADA 2023 guidelines
Type 1 diabetes education
Prediabetes education
Metformin indications, monitoring, education, adverse effects, MOA
Propranolol indications for endocrine disorders
Hyperthyroidism treatment considerations
Biguanides MOA
SGLT-2i adverse effects
GLP-1 side effects and adverse effects
Sulfonylureas adverse effects
Insulin adjustments
Week 6: Pharmacotherapy for Respiratory Conditions, Chapters 64 & 79
Asthma goals
Albuterol education
Salmeterol education
Montelukast indications, side effects and adverse effects
Inhaled glucocorticoid adverse effect management, special populations, MOA
Systemic glucocorticoid adverse effects
LABA safe prescribing
SABA education
Anticholinergics MOA
Theophylline drug interaction
Asthma controller
Asthma treating special populations
Exam Study Guide – Final Exam
Exam Format: Non-Cumulative Exam
Question Type: Multiple Choice
Number of Questions: 100
Time Allotted: 120 minutes (1.2 minutes per question)
Testing Timeframe: The final exam will be available starting on
Wednesday Week 8 at 12:01 am MT until Saturday Week 8 at 11:59 pm
MT.
1. Exam Coverage
Content Areas:
Week 5: Pharmacotherapy for Endocrine Disorders
Week 6: Pharmacotherapy for Respiratory Conditions
Week 7: Pharmacotherapy for Gastrointestinal Conditions
Week 8: Complementary and Alternative Therapies
2. Key Concepts to Study
Week 5: Pharmacotherapy for Endocrine Disorders, Chapters 48-49
Radioactive iodine adverse effects
Methimazole indication and MOA
Levothyroxine education, population considerations, monitoring, drug
interactions, dosing, adjustments
Pioglitazone contraindications
Gemfibrozil drug interactions
Insulin detemir dosing, duration, and indications
, Insulin glargine administration
ADA 2023 guidelines
Type 1 diabetes education
Prediabetes education
Metformin indications, monitoring, education, adverse effects, MOA
Propranolol indications for endocrine disorders
Hyperthyroidism treatment considerations
Biguanides MOA
SGLT-2i adverse effects
GLP-1 side effects and adverse effects
Sulfonylureas adverse effects
Insulin adjustments
Week 6: Pharmacotherapy for Respiratory Conditions, Chapters 64 & 79
Asthma goals
Albuterol education
Salmeterol education
Montelukast indications, side effects and adverse effects
Inhaled glucocorticoid adverse effect management, special populations, MOA
Systemic glucocorticoid adverse effects
LABA safe prescribing
SABA education
Anticholinergics MOA
Theophylline drug interaction
Asthma controller
Asthma treating special populations